Tesla Inc.'s (NASDAQ:TSLA) rally isn't just about EVs anymore — it's about who owns the future of robotics. As shares hover near 2025 highs, investors are increasingly treating autonomy, Optimus, and Robotaxi ambitions as core drivers of value rather than…
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) stock rose Monday, with a session volume of 6.80 million compared to the average volume of 696.68 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2…
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) stock rose Monday, with a session volume of 6.80 million compared to the average volume of 696.68 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2…
ServiceNow (NYSE:NOW) is reportedly in advanced talks to acquire cybersecurity firm Armis, which could value the startup at up to $7 billion, according to people familiar with the matter. The transaction could be announced in the coming days, though negotiations are…
ServiceNow (NYSE:NOW) is reportedly in advanced talks to acquire cybersecurity firm Armis, which could value the startup at up to $7 billion, according to people familiar with the matter. The transaction could be announced in the coming days, though negotiations are…
On Friday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson's (NYSE:JNJ) supplemental New Drug Application (sNDA) for Akeega (niraparib and abiraterone acetate) plus prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC). Patients with BRCA mutations often have…
Broadcom Inc (NASDAQ:AVGO) may have delivered strong AI revenue growth that grabbed headlines, but a deeper look at how that growth is structured highlights a risk that's less of a concern for Nvidia Corp (NASDAQ:NVDA) — concentration of demand and…
Visa Inc. (NYSE:V) on Monday announced the launch of its Stablecoins Advisory Practice, expanding its push into digital payments and blockchain-based settlement. This new service, offered through Visa Consulting & Analytics (VCA), delivers actionable insights and guidance to help banks,…
Cencora, Inc. (NYSE:COR) on Monday agreed to acquire the majority stake it does not own in OneOncology from TPG and other shareholders for. Cencora stock is showing positive momentum. What’s next for COR stock? The consideration includes approximately $3.6 billion…
On Friday, the U.S. Food and Drug Administration (FDA) approved Milestone Pharmaceuticals Inc.’s (NASDAQ:MIST) first commercial product, Cardamyst (etripamil) nasal spray. The approval covers the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.…